Grail, Llc Stock Short Ratio
| GRAL Stock | 18.72 0.37 2.02% |
GRAIL, LLC fundamentals help investors to digest information that contributes to GRAIL, LLC's financial success or failures. It also enables traders to predict the movement of GRAIL, Stock. The fundamental analysis module provides a way to measure GRAIL, LLC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GRAIL, LLC stock.
GRAIL, | Short Ratio |
GRAIL, LLC Company Short Ratio Analysis
GRAIL, LLC's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current GRAIL, LLC Short Ratio | 6.73 X |
Most of GRAIL, LLC's fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GRAIL, LLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
GRAIL, Short Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for GRAIL, LLC is extremely important. It helps to project a fair market value of GRAIL, Stock properly, considering its historical fundamentals such as Short Ratio. Since GRAIL, LLC's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of GRAIL, LLC's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of GRAIL, LLC's interrelated accounts and indicators.
Click cells to compare fundamentals
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
GRAIL, Price To Sales Ratio
Price To Sales Ratio |
|
Based on the latest financial disclosure, GRAIL, LLC has a Short Ratio of 6.73 times. This is 72.56% higher than that of the Biotechnology sector and 15.64% higher than that of the Health Care industry. The short ratio for all United States stocks is 68.25% lower than that of the firm.
GRAIL, Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GRAIL, LLC's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GRAIL, LLC could also be used in its relative valuation, which is a method of valuing GRAIL, LLC by comparing valuation metrics of similar companies.GRAIL, LLC is currently under evaluation in short ratio category among its peers.
GRAIL, LLC Current Valuation Drivers
We derive many important indicators used in calculating different scores of GRAIL, LLC from analyzing GRAIL, LLC's financial statements. These drivers represent accounts that assess GRAIL, LLC's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of GRAIL, LLC's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Enterprise Value | 3.1B | 1.6B | 1.6B | 278.6M | 411.3M | 390.7M |
GRAIL, Fundamentals
| Operating Margin | (6.40) % | ||||
| Current Valuation | (164.11 M) | ||||
| Shares Outstanding | 33.6 M | ||||
| Shares Owned By Insiders | 13.75 % | ||||
| Shares Owned By Institutions | 67.05 % | ||||
| Number Of Shares Shorted | 4.38 M | ||||
| Price To Book | 0.24 X | ||||
| Price To Sales | 5.24 X | ||||
| Revenue | 93.11 M | ||||
| EBITDA | (620.9 M) | ||||
| Net Income | (1.47 B) | ||||
| Total Debt | 84.41 M | ||||
| Book Value Per Share | 77.93 X | ||||
| Cash Flow From Operations | (595.8 M) | ||||
| Short Ratio | 6.73 X | ||||
| Earnings Per Share | (58.29) X | ||||
| Target Price | 16.0 | ||||
| Number Of Employees | 1.36 K | ||||
| Market Capitalization | 616.57 M | ||||
| Total Asset | 3.91 B | ||||
| Retained Earnings | (7.78 B) | ||||
| Working Capital | (7.54 M) | ||||
| Net Asset | 3.91 B |
About GRAIL, LLC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GRAIL, LLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GRAIL, LLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GRAIL, LLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out GRAIL, LLC Piotroski F Score and GRAIL, LLC Altman Z Score analysis. For more information on how to buy GRAIL, Stock please use our How to buy in GRAIL, Stock guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GRAIL, LLC. If investors know GRAIL, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GRAIL, LLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (58.29) | Revenue Per Share 3.544 | Quarterly Revenue Growth 0.383 |
The market value of GRAIL, LLC is measured differently than its book value, which is the value of GRAIL, that is recorded on the company's balance sheet. Investors also form their own opinion of GRAIL, LLC's value that differs from its market value or its book value, called intrinsic value, which is GRAIL, LLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GRAIL, LLC's market value can be influenced by many factors that don't directly affect GRAIL, LLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GRAIL, LLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if GRAIL, LLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GRAIL, LLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.